 | • レポートコード：B-GIR08C0781 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、全身性エリテマトーデス生物製剤の世界市場について調べ、まとめました。種類別セグメントは、リツキシマブ、ベリムマブ、アニフロルマブ、UBP-1213、その他等、用途別セグメントは、商業用途、家族用途、実験室用途、その他等に区分しました。全身性エリテマトーデス生物製剤の世界市場概観、企業動向、企業別全身性エリテマトーデス生物製剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・全身性エリテマトーデス生物製剤の市場概観 ・全身性エリテマトーデス生物製剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・全身性エリテマトーデス生物製剤の企業別販売動向、市場シェア、市場集中度、競争動向 ・全身性エリテマトーデス生物製剤の世界市場規模 ・全身性エリテマトーデス生物製剤の北米市場分析（アメリカ、カナダ、メキシコ等） ・全身性エリテマトーデス生物製剤のアメリカ市場規模推移 ・全身性エリテマトーデス生物製剤のカナダ市場規模推移 ・全身性エリテマトーデス生物製剤のメキシコ市場規模推移 ・全身性エリテマトーデス生物製剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・全身性エリテマトーデス生物製剤のドイツ市場規模推移 ・全身性エリテマトーデス生物製剤のイギリス市場規模推移 ・全身性エリテマトーデス生物製剤のロシア市場規模推移 ・全身性エリテマトーデス生物製剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・全身性エリテマトーデス生物製剤の日本市場規模推移 ・全身性エリテマトーデス生物製剤の中国市場規模推移 ・全身性エリテマトーデス生物製剤の韓国市場規模推移 ・全身性エリテマトーデス生物製剤のインド市場規模推移 ・全身性エリテマトーデス生物製剤の東南アジア市場規模推移 ・全身性エリテマトーデス生物製剤の南米市場分析（ブラジル、アルゼンチン等） ・全身性エリテマトーデス生物製剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・全身性エリテマトーデス生物製剤の種類別分析/販売量、売上、市場シェア（リツキシマブ、ベリムマブ、アニフロルマブ、UBP-1213、その他） ・全身性エリテマトーデス生物製剤の用途別分析/市場規模（商業用途、家族用途、実験室用途、その他） ・全身性エリテマトーデス生物製剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・全身性エリテマトーデス生物製剤の販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The global Biologicals for Systemic Lupus Erythematosus market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biologicals for Systemic Lupus Erythematosus.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Biologicals for Systemic Lupus Erythematosus market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biologicals for Systemic Lupus Erythematosus market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche
GlaxoSmithKline
Shanghai Junshi Biosciences
ACEA Biosciences
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Rituximab
Belimumab
Anifrolumab
UBP-1213
Other
Market Segment by Applications, can be divided into
Hospital
Clinic
Pharmacy
Other
Table of Contents
1 Biologicals for Systemic Lupus Erythematosus Market Overview
1.1 Product Overview and Scope of Biologicals for Systemic Lupus Erythematosus
1.2 Classification of Biologicals for Systemic Lupus Erythematosus by Types
1.2.1 Global Biologicals for Systemic Lupus Erythematosus Revenue Comparison by Types (2019-2024)
1.2.2 Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Types in 2018
1.2.3 Rituximab
1.2.4 Belimumab
1.2.5 Anifrolumab
1.2.6 UBP-1213
1.2.7 Other
1.3 Global Biologicals for Systemic Lupus Erythematosus Market by Application
1.3.1 Global Biologicals for Systemic Lupus Erythematosus Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.3.5 Other
1.4 Global Biologicals for Systemic Lupus Erythematosus Market by Regions
1.4.1 Global Biologicals for Systemic Lupus Erythematosus Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Biologicals for Systemic Lupus Erythematosus Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Biologicals for Systemic Lupus Erythematosus Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biologicals for Systemic Lupus Erythematosus Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Biologicals for Systemic Lupus Erythematosus Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biologicals for Systemic Lupus Erythematosus Status and Prospect (2014-2024)
1.5 Global Market Size of Biologicals for Systemic Lupus Erythematosus (2014-2024)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Biologicals for Systemic Lupus Erythematosus Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Biologicals for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.2 GlaxoSmithKline
2.2.1 Business Overview
2.2.2 Biologicals for Systemic Lupus Erythematosus Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.3 Shanghai Junshi Biosciences
2.3.1 Business Overview
2.3.2 Biologicals for Systemic Lupus Erythematosus Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
2.4 ACEA Biosciences
2.4.1 Business Overview
2.4.2 Biologicals for Systemic Lupus Erythematosus Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
3 Global Biologicals for Systemic Lupus Erythematosus Market Competition, by Players
3.1 Global Biologicals for Systemic Lupus Erythematosus Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Biologicals for Systemic Lupus Erythematosus Players Market Share
3.2.2 Top 10 Biologicals for Systemic Lupus Erythematosus Players Market Share
3.3 Market Competition Trend
4 Global Biologicals for Systemic Lupus Erythematosus Market Size by Regions
4.1 Global Biologicals for Systemic Lupus Erythematosus Revenue and Market Share by Regions
4.2 North America Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
4.3 Europe Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
4.5 South America Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
5 North America Biologicals for Systemic Lupus Erythematosus Revenue by Countries
5.1 North America Biologicals for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
5.2 USA Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
5.3 Canada Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
5.4 Mexico Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
6 Europe Biologicals for Systemic Lupus Erythematosus Revenue by Countries
6.1 Europe Biologicals for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
6.2 Germany Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
6.3 UK Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
6.4 France Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
6.5 Russia Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
6.6 Italy Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Biologicals for Systemic Lupus Erythematosus Revenue by Countries
7.1 Asia-Pacific Biologicals for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
7.2 China Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
7.3 Japan Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
7.4 Korea Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
7.5 India Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
8 South America Biologicals for Systemic Lupus Erythematosus Revenue by Countries
8.1 South America Biologicals for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
8.2 Brazil Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
8.3 Argentina Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
8.4 Colombia Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Biologicals for Systemic Lupus Erythematosus by Countries
9.1 Middle East and Africa Biologicals for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
9.2 Saudi Arabia Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
9.3 UAE Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
9.4 Egypt Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
9.5 Nigeria Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
9.6 South Africa Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
10 Global Biologicals for Systemic Lupus Erythematosus Market Segment by Type
10.1 Global Biologicals for Systemic Lupus Erythematosus Revenue and Market Share by Type (2014-2019)
10.2 Global Biologicals for Systemic Lupus Erythematosus Market Forecast by Type (2019-2024)
10.3 Rituximab Revenue Growth Rate (2014-2024)
10.4 Belimumab Revenue Growth Rate (2014-2024)
10.5 Anifrolumab Revenue Growth Rate (2014-2024)
10.6 UBP-1213 Revenue Growth Rate (2014-2024)
10.7 Other Revenue Growth Rate (2014-2024)
11 Global Biologicals for Systemic Lupus Erythematosus Market Segment by Application
11.1 Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Application (2014-2019)
11.2 Biologicals for Systemic Lupus Erythematosus Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Pharmacy Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Biologicals for Systemic Lupus Erythematosus Market Size Forecast (2019-2024)
12.1 Global Biologicals for Systemic Lupus Erythematosus Market Size Forecast (2019-2024)
12.2 Global Biologicals for Systemic Lupus Erythematosus Market Forecast by Regions (2019-2024)
12.3 North America Biologicals for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
12.4 Europe Biologicals for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Biologicals for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
12.6 South America Biologicals for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Biologicals for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Biologicals for Systemic Lupus Erythematosus Picture
Table Product Specifications of Biologicals for Systemic Lupus Erythematosus
Table Global Biologicals for Systemic Lupus Erythematosus and Revenue (Million USD) Market Split by Product Type
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Types in 2018
Figure Rituximab Picture
Figure Belimumab Picture
Figure Anifrolumab Picture
Figure UBP-1213 Picture
Figure Other Picture
Table Global Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) by Application (2014-2024)
Figure Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Pharmacy Picture
Figure Other Picture
Table Global Market Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (2014-2024)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Biologicals for Systemic Lupus Erythematosus Type and Applications
Table Roche Biologicals for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Type and Applications
Table GlaxoSmithKline Biologicals for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai Junshi Biosciences Basic Information, Manufacturing Base and Competitors
Table Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Type and Applications
Table Shanghai Junshi Biosciences Biologicals for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table ACEA Biosciences Basic Information, Manufacturing Base and Competitors
Table ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Type and Applications
Table ACEA Biosciences Biologicals for Systemic Lupus Erythematosus Revenue, Gross Margin and Market Share (2017-2018)
Table Global Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) by Players (2014-2019)
Table Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Players (2014-2019)
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Players in 2017
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Players in 2018
Figure Global Top 5 Players Biologicals for Systemic Lupus Erythematosus Revenue Market Share in 2018
Figure Global Top 10 Players Biologicals for Systemic Lupus Erythematosus Revenue Market Share in 2018
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) by Regions (2014-2019)
Table Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Regions (2014-2019)
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Regions (2014-2019)
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Regions in 2018
Figure North America Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Europe Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure South America Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table North America Biologicals for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
Table North America Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure North America Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure North America Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries in 2018
Figure USA Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Canada Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Mexico Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table Europe Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) by Countries (2014-2019)
Figure Europe Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure Europe Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries in 2018
Figure Germany Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure UK Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure France Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Russia Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Italy Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries in 2018
Figure China Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Japan Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Korea Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure India Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table South America Biologicals for Systemic Lupus Erythematosus Revenue by Countries (2014-2019)
Table South America Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure South America Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure South America Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries in 2018
Figure Brazil Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Argentina Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Colombia Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Biologicals for Systemic Lupus Erythematosus Revenue Market Share by Countries in 2018
Figure Saudi Arabia Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure UAE Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Egypt Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure Nigeria Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Figure South Africa Biologicals for Systemic Lupus Erythematosus Revenue and Growth Rate (2014-2019)
Table Global Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) by Type (2014-2019)
Table Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Type (2014-2019)
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Type (2014-2019)
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Type in 2018
Table Global Biologicals for Systemic Lupus Erythematosus Revenue Forecast by Type (2019-2024)
Figure Global Biologicals for Systemic Lupus Erythematosus Market Share Forecast by Type (2019-2024)
Figure Global Rituximab Revenue Growth Rate (2014-2019)
Figure Global Belimumab Revenue Growth Rate (2014-2019)
Figure Global Anifrolumab Revenue Growth Rate (2014-2019)
Figure Global UBP-1213 Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Biologicals for Systemic Lupus Erythematosus Revenue by Application (2014-2019)
Table Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Application (2014-2019)
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Application (2014-2019)
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue Share by Application in 2018
Table Global Biologicals for Systemic Lupus Erythematosus Revenue Forecast by Application (2019-2024)
Figure Global Biologicals for Systemic Lupus Erythematosus Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Pharmacy Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Biologicals for Systemic Lupus Erythematosus Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Biologicals for Systemic Lupus Erythematosus Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Biologicals for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
Figure Europe Biologicals for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Biologicals for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
Figure South America Biologicals for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Biologicals for Systemic Lupus Erythematosus Revenue Market Forecast (2019-2024)
全身性エリテマトーデス用グルココルチコイドの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Glucocorticoid for Systemic Lupus Erythematosus market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years…- 世界のループス腎炎市場：市場規模・現状・予測 Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. Whil…
- 世界の全身性アスペルギルス症と全身性カンジダ症市場2019 The global Systemic Aspergillosis and Systemic Candidasis market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Systemic Aspergillosis and Systemic Candidasis market status and forecast, categoriz…
- 全身性硬化症治療の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Systemic sclerosis is a rare but serious autoimmune disease which causes hardening and swelling of the skin, as well as joint pain, digestive problems, lung disease, and sometimes problems with the heart and kidneys. Scope of the Report: The global Systemic Sclerosis Treatments market is valued at x…
- 皮膚・全身性リーシュマニア症薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Cutaneous and Systemic Leishmaniasis is the most common syndrome and can produce ulcers that have the potential of stimulating a periosteal reaction if the ulcer occurs near bone. Scope of the Report: The global Cutaneous and Systemic Leishmaniasis Drugs market is valued at xx million USD in 2018 an…